Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a valsartan/Hydrochlorothiazide combination for severe hypertension has completed. The update notes completion but does not provide tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Valsartan/Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED